Top

Published in:

01-06-2010 | Original Paper

Provider-related Barriers to Rapid HIV Testing in U.S. Urban Non-profit Community Clinics, Community-based Organizations (CBOs) and Hospitals

Authors: Laura M. Bogart, Devery Howerton, James Lange, Claude Messan Setodji, Kirsten Becker, David J. Klein, Steven M. Asch

Published in: AIDS and Behavior | Issue 3/2010

Abstract

We examined provider-reported barriers to rapid HIV testing in U.S. urban non-profit community clinics, community-based organizations (CBOs), and hospitals. 12 primary metropolitan statistical areas (PMSAs; three per region) were sampled randomly, with sampling weights proportional to AIDS case reports. Across PMSAs, all 671 hospitals and a random sample of 738 clinics/CBOs were telephoned for a survey on rapid HIV test availability. Of the 671 hospitals, 172 hospitals were randomly selected for barriers questions, for which 158 laboratory and 136 department staff were eligible and interviewed in 2005. Of the 738 clinics/CBOs, 276 were randomly selected for barriers questions, 206 were reached, and 118 were eligible and interviewed in 2005–2006. In multivariate models, barriers regarding translation of administrative/quality assurance policies into practice were significantly associated with rapid HIV testing availability. For greater rapid testing diffusion, policies are needed to reduce administrative barriers and provide quality assurance training to non-laboratory staff.

ACOG Committee on Obstetric Practice. (2004). ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: Expanded recommendations. Obstetrics and Gynecology, 104, 1119–1124.

Bogart, L. M., Howerton, D., Lange, J., Becker, K., Setodji, C. M., & Asch, S. M. (2008a). Scope of rapid HIV testing in private nonprofit urban community health settings in the United States. American Journal of Public Health, 98, 736–742. doi:10.2105/AJPH.2007.111567.CrossRefPubMed

Bogart, L. M., Howerton, D., Lange, J., Becker, K., Setodji, C. M., & Asch, S. M. (2008b). Scope of rapid HIV testing in urban U.S. hospitals. Public Health Reports, 123, 494–503.PubMed

Bucher, J. B., Thomas, K. M., Guzman, D., Riley, E., Dela Cruz, N., & Bangsberg, D. R. (2007). Community-based rapid HIV testing in homeless and marginally housed adults in San Francisco. HIV Medicine, 8, 28–31. doi:10.1111/j.1468-1293.2007.00423.x.CrossRefPubMed

Bulterys, M., Jamieson, D. J., O’Sullivan, M. J., Cohen, M. H., Maupin, R., Nesheim, S., et al. (2004). Rapid HIV-1 testing during labor: A multicenter study. Journal of the American Medical Association, 292, 219–223. doi:10.1001/jama.292.2.219.CrossRefPubMed

Burke, R. C., Sepkowitz, K. A., Bernstein, K. T., Karpati, A. M., Meyers, J. E., Tsoi, B. W., et al. (2007). Why don’t physicians test for HIV? A review of the U.S. literature. AIDS (London, England), 21, 1617–1624. doi:10.1097/QAD.0b013e32823f91ff.

Centers for Disease Control and Prevention. (1994). HIV counseling, testing and referral standards and guidelines. Atlanta, GA: U.S: Department of Health and Human Services Public Health Service, CDC.

Centers for Disease Control and Prevention. (2001a). HIV and AIDS—United States, 1981–2001. Morbidity and Mortality Weekly Report, 50, 430–434.

Centers for Disease Control and Prevention. (2001b). Revised guidelines for HIV counseling, testing, and referral. Morbidity and Mortality Weekly Report, 50, 1–58.

Centers for Disease Control and Prevention. (2004a). Notice to readers: Protocols for confirmation of reactive rapid HIV tests. Morbidity and Mortality Weekly Report, 53, 221–222.

Centers for Disease Control and Prevention. (2004b). Number of persons tested for HIV—United States, 2002. Morbidity and Mortality Weekly Report, 53, 1110–1113.

Centers for Disease Control and Prevention. (2005). Demonstration projects for community-based organizations (CBOs): HIV rapid testing in non-clinical settings. Atlanta: Centers for Disease Control and Prevention.

Centers for Disease Control and Prevention. (2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbidity and Mortality Weekly Report, 55, 1–17.

Centers for Disease Control and Prevention. (2007a). Basic statistics. Retrieved May 22, 2008, from http://www.cdc.gov/hiv/topics/surveillance/basic.htm.

Centers for Disease Control and Prevention. (2007b). General and laboratory considerations: Rapid HIV tests currently available in the United States. U.S. Department of Health and Human Services Retrieved November 9, 2007, from http://www.cdc.gov/hiv/topics/testing/resources/factsheets/rt-lab.htm.

Centers for Disease Control and Prevention. (2007c). Quality assurance guidelines for testing using rapid HIV antibody tests waived under the clinical laboratory improvement amendments of 1988. U.S. Department of Health and Human Services Retrieved October 22, 2007, from http://www.cdc.gov/hiv/topics/testing/resources/guidelines/pdf/QA_Guidlines.pdf.

Centers for Disease Control and Prevention. (2007d). Rapid HIV testing in emergency departments—Three U.S. sites, January 2005–March 2006. Morbidity and Mortality Weekly Report, 56, 597–601.

Centers for Disease Control and Prevention. (2007e). Strategic planning workshops for implementation of HIV screening in acute care settings. U.S. Department of Health and Human Services Retrieved November 9, 2007, from http://www.cdc.gov/hiv/topics/testing/rapid/rt-training.htm.

Chembio Diagnostic Systems Inc. (2007a). Clearview COMPLETE HIV 1/2. Medford, NY: Package Insert.

Chembio Diagnostic Systems Inc. (2007b). Clearview HIV 1/2 STAT-PAK. Medford, NY: Package Insert.

Cohen, M. H., Olszewski, Y., Robey, M., Love, F., Branson, B., Jamieson, D. J., et al. (2003). Rapid point-of-care testing for HIV-1 during labor and delivery. Morbidity and Mortality Weekly Report, 52, 866–867.

Delaney, K. P., Branson, B. M., Uniyal, A., Kerndt, P. R., Keenan, P. A., Jafa, K., et al. (2006). Performance of an oral fluid rapid HIV-1/2 test: Experience from four CDC studies. AIDS (London, England), 20, 1655–1660. doi:10.1097/01.aids.0000238412.75324.82.

Doyle, N., Levison, J., & Gardner, M. (2005). Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: A cost-effectiveness analysis. American Journal of Obstetrics and Gynecology, 193, 1280–1285. doi:10.1016/j.ajog.2005.07.001.CrossRefPubMed

Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002). Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Annals of Internal Medicine, 137, 381–433.PubMed

Ekwueme, D. U., Pinkerton, S. D., Holtgrave, D. R., & Branson, B. M. (2003). Cost comparison of three HIV counseling and testing technologies. American Journal of Preventive Medicine, 25, 112–121. doi:10.1016/S0749-3797(03)00115-6.CrossRefPubMed

Forsyth, B. W., Barringer, S. R., Walls, T. A., Landry, M. L., Ferguson, D., Tinghitella, T. J., et al. (2004). Rapid HIV testing of women in labor: Too long a delay. Journal of Acquired Immune Deficiency Syndromes, 35, 151–154. doi:10.1097/00126334-200402010-00008.CrossRefPubMed

Galvan, F. H., Brooks, R. A., & Leibowitz, A. A. (2004). Rapid HIV testing: Issues in implementation. AIDS Patient Care and STDs, 18, 15–18. doi:10.1089/108729104322740875.CrossRefPubMed

Glynn, M., & Rhodes, P. (2005). Estimated HIV prevalence in the United States at the end of 2003. Paper presented at the National HIV Prevention Conference, June 2005, Atlanta, GA.

Greenwald, J. L., Burstein, G. R., Pincus, J., & Branson, B. (2006). A rapid review of rapid HIV antibody tests. Current Infectious Disease Reports, 8, 125–131. doi:10.1007/s11908-006-0008-6.CrossRefPubMed

Guay, L. A., Musoke, P., Fleming, T., Bagenda, D., Allen, M., Nakabiito, C., et al. (1999). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 354, 795–802.PubMed

Hall, I. H., Song, R., Rhodes, P., Prejean, J., An, Q., Lee, L. M., et al. (2008). Estimation of HIV incidence in the United States. Journal of the American Medical Association, 300, 520–529. doi:10.1001/jama.300.5.520.CrossRefPubMed

Health Research and Educational Trust. (2007). HIV testing in emergency departments: A practical guide. Retrieved October 22, 2007, from http://www.edhivtestguide.org/.

Hutchinson, A. B., Branson, B. M., Kim, A., & Farnham, P. G. (2006). A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS (London, England), 20, 1597–1604. doi:10.1097/01.aids.0000238405.93249.16.

Hutchinson, A. B., Corbie-Smith, G., Thomas, S. B., Mohanan, S., & del Rio, C. (2004). Understanding the patient’s perspective on rapid and routine HIV testing in an inner-city urgent care center. AIDS Education and Prevention, 16, 101–114. doi:10.1521/aeap.16.2.101.29394.CrossRefPubMed

Jamieson, D. J., Cohen, M. H., Maupin, R., Nesheim, S., Danner, S. P., Lampe, M. A., et al. (2007). Rapid human immunodeficiency virus-1 testing on labor and delivery in 16 U.S. hospitals: The MIRIAD experience. American Journal of Obstetrics and Gynecology, 197, S72–S82. doi:10.1016/j.ajog.2007.03.067.CrossRefPubMed

Kaiser, H. F. (1960). The application of electronic computers to factor analysis. Educational and Psychological Measurement, 20, 141–151. doi:10.1177/001316446002000116.CrossRef

Karon, J. M., Fleming, P. L., Steketee, R. W., & De Cock, K. M. (2001). HIV in the United States at the turn of the century: An epidemic in transition. American Journal of Public Health, 91, 1060–1068.CrossRefPubMed

Kassler, W. J., Dillon, B. A., Haley, C., Jones, W. K., & Goldman, A. (1997). On-site, rapid HIV testing with same-day results and counseling. AIDS (London, England), 11, 1045–1051. doi:10.1097/00002030-199708000-00014.

Kelen, G. D., Shahan, J. B., & Quinn, T. C. (1999). Emergency department-based HIV screening and counseling: Experience with rapid and standard serologic testing. Annals of Emergency Medicine, 33, 147–155. doi:10.1016/S0196-0644(99)70387-2.CrossRefPubMed

Lampe, M., Branson, B., Paul, S., Burr, C., Gross, E., Eicher, C., et al. (2004). Rapid HIV-1 antibody testing during labor and delivery for women of unknown HIV status: A practical guide and model protocol. Retrieved October 22, 2007, from http://www.cdc.gov/hiv/topics/testing/resources/guidelines/pdf/Labor&DeliveryRapidTesting.pdf.

Landrum, M. L., Wilson, C. H., Perri, L. P., Hannibal, S. L., & O’Connell, R. J. (2005). Usefulness of a rapid human immunodeficiency virus-1 antibody test for the management of occupational exposure to blood and body fluid. Infection Control and Hospital Epidemiology, 26, 768–774. doi:10.1086/502615.CrossRefPubMed

Lubelchek, R., Kroc, K., Hota, B., Sharief, R., Muppudi, U., Pulvirenti, J., et al. (2005). The role of rapid vs conventional human immunodeficiency virus testing for inpatients: Effects on quality of care. Archives of Internal Medicine, 165, 1956–1960. doi:10.1001/archinte.165.17.1956.CrossRefPubMed

Macgowan, R., Margolis, A., Richardson-Moore, A., Wang, T., Lalota, M., French, P. T., et al. (2007). Voluntary rapid Human Immunodeficiency Virus (HIV) testing in jails. Sexually Transmitted Diseases, 34. (Epub ahead of print).

Marks, G., Crepaz, N., Senterfitt, J. W., & Janssen, R. S. (2005). Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes, 39, 446–453. doi:10.1097/01.qai.0000151079.33935.79.CrossRefPubMed

Merchant, R. C., Gee, E. M., Clark, M. A., Mayer, K. H., Seage, G. R., III, & Degruttola, V. G. (2007). Comparison of patient comprehension of rapid HIV pre-test fundamentals by information delivery format in an emergency department setting. BMC Public Health, 7, 238. doi:10.1186/1471-2458-7-238.CrossRefPubMed

Obermeyer, C. M., & Osborn, M. (2007). The utilization of testing and counseling for HIV: A review of the social and behavioral evidence. American Journal of Public Health, 97, 1762–1774. doi:10.2105/AJPH.2006.096263.CrossRefPubMed

OraSure Technologies. (2004). OraQuick advance rapid HIV1-2 antibody test. Bethlehem, PA: Package Insert.

Pai, N. P., Tulsky, J. P., Cohan, D., Colford, J. M., Jr, & Reingold, A. L. (2007). Rapid point-of-care HIV testing in pregnant women: A systematic review and meta-analysis. Tropical Medicine & International Health, 12, 162–173.

Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. The New England Journal of Medicine, 338, 853–860. doi:10.1056/NEJM199803263381301.CrossRefPubMed

Plate, D. K., & Rapid HIV Test Evaluation Working Group. (2007). Evaluation and implementation of rapid HIV tests: The experience in 11 African countries. AIDS Research and Human Retroviruses, 23, 1491–1498. doi:10.1089/aid.2007.0020.CrossRefPubMed

Robles, A. M., & Stringer, H. G. (2006). HIV-AIDS in minorities. Clinics in Chest Medicine, 27, 511–519. doi:10.1016/j.ccm.2006.04.010.CrossRefPubMed

Rotheram-Borus, M. J., Leibowitz, A. A., & Etzel, M. A. (2006). Routine, rapid HIV testing. AIDS Education and Prevention, 18, 273–280. doi:10.1521/aeap.2006.18.3.273.CrossRefPubMed

San Antonio-Gaddy, M., Richardson-Moore, A., Burstein, G. R., Newman, D. R., Branson, B. M., & Birkhead, G. S. (2006). Rapid HIV antibody testing in the New York State anonymous HIV counseling and testing program experience from the field. Journal of Acquired Immune Deficiency Syndromes, 43, 446–450. doi:10.1097/01.qai.0000243055.65698.51.CrossRefPubMed

Spielberg, F., Branson, B. M., Goldbaum, G. M., Lockhart, D., Kurth, A., Rossini, A., et al. (2005). Choosing HIV counseling and testing strategies for outreach settings: A randomized trial. Journal of Acquired Immune Deficiency Syndromes, 38, 348–355.PubMed

Steen, T. W., Seipone, K., Gomez Fde, L., Anderson, M. G., Kejelepula, M., Keapoletswe, K., et al. (2007). Two and a half years of routine HIV testing in Botswana. Journal of Acquired Immune Deficiency Syndromes, 44, 484–488. doi:10.1097/QAI.0b013e318030ffa9.CrossRefPubMed

Stokes, S. H. M., McCaster, P., & Ismail, K. M. K. (2007). Acceptability of perinatal rapid point-of-care HIV testing in an area of low HIV prevalence in the UK. Archives of Disease in Childhood, 92, 505–508. doi:10.1136/adc.2006.106070.CrossRefPubMed

Trinity Biotech, P.L.C. (2004). Uni-Gold ^TM Recombigen® HIV. Wicklow, Ireland: Package Insert.

Wesolowski, L. G., MacKellar, D. A., Facente, S. N., Dowling, T., Ethridge, S. F., Zhu, J. H., et al. (2006). Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS (London, England), 20, 1661–1666. doi:10.1097/01.aids.0000238413.13442.ed.

Wolf, L. E., Donoghoe, A., & Lane, T. (2007). Implementing routine HIV testing: The role of state law. PLoS ONE, 2, e1005. doi:10.1371/journal.pone.0001005.CrossRefPubMed

Wurcel, A., Zaman, T., Shen, S., & Stone, D. (2005). Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: A study of rapid versus standard testing. AIDS Patient Care and STDs, 19, 499–505. doi:10.1089/apc.2005.19.499.CrossRefPubMed

Zierler, S., Krieger, N., Tang, Y., Coady, W., Siegfried, E., DeMaria, A., et al. (2000). Economic deprivation and AIDS incidence in Massachusetts. American Journal of Public Health, 90, 1064–1073.CrossRefPubMed

Title: Provider-related Barriers to Rapid HIV Testing in U.S. Urban Non-profit Community Clinics, Community-based Organizations (CBOs) and Hospitals
Authors: Laura M. Bogart
Devery Howerton
James Lange
Claude Messan Setodji
Kirsten Becker
David J. Klein
Steven M. Asch
Publication date: 01-06-2010
Publisher: Springer US
Published in: AIDS and Behavior / Issue 3/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-008-9456-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2010

Randomized Trial of the Effects of Housing Assistance on the Health and Risk Behaviors of Homeless and Unstably Housed People Living with HIV

Reducing HIV Risks Among Active Injection Drug and Crack Users: The Safety Counts Program

Barriers to Pharmacy-Based Syringe Purchase Among Injection Drug Users in Tijuana, Mexico: A Mixed Methods Study

Brief and Intensive Behavioral Interventions to Promote Sexual Risk Reduction among STD Clinic Patients: Results from a Randomized Controlled Trial

Efficacy of a Web-Based Intervention to Reduce Sexual Risk in Men Who Have Sex with Men

An Exploratory Behavioral Intervention Trial to Improve Rates of Screening for AIDS Clinical Trials Among Racial/Ethnic Minority and Female Persons Living with HIV/AIDS

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage